How should symptomatic nephrolithiasis (renal colic) be managed in a woman in the third trimester of pregnancy?

Management of Nephrolithiasis in Third Trimester of Pregnancy

For symptomatic nephrolithiasis in the third trimester, initial conservative management with observation and trial of passage should be offered, with ureteroscopy (URS) as the definitive intervention if conservative management fails or is not appropriate. 1

Initial Diagnostic Approach

Imaging should follow a stepwise algorithm:

• First-line: Ultrasound (US) - strongly recommended as the initial diagnostic modality 2
• Second-line: MRI - if diagnostic uncertainty persists after ultrasound 2
• Last resort: Low-dose CT - only when US and MRI are insufficient, with involvement of obstetric team, radiology, and potentially medical physicist 1, 2

This hierarchy minimizes fetal radiation exposure while maintaining diagnostic accuracy. The 2025 EAU guidelines provide the most current imaging recommendations for pregnant patients 2.

Pain Management

NSAIDs are contraindicated in the third trimester due to risks of premature ductus arteriosus closure and oligohydramnios. While NSAIDs (diclofenac, ibuprofen, metamizole) are first-line for renal colic in non-pregnant patients 2, opioids become the primary analgesic option in the third trimester. Avoid pethidine due to high vomiting rates; instead use hydromorphine, pentazocine, or tramadol 2.

Conservative Management Strategy

Initial approach for well-controlled symptoms:

• Observation with trial of passage is appropriate for stable patients 1
• Stone passage rates during pregnancy range from 40-60%, with mean passage time of 17-35 days 1
• Tamsulosin for medical expulsive therapy has NOT been proven effective in pregnancy - two RCTs showed no significant benefit, though no adverse maternal or fetal effects were noted 1

Critical caveat: Patients must be counseled that delayed intervention may be required if conservative management fails, and intractable symptoms should prompt immediate consideration of intervention 1.

Indications for Urgent Intervention

Immediate decompression is mandatory for:

• Sepsis with obstructed kidney
• Anuria from bilateral obstruction or obstruction of solitary kidney

Decompression options: Percutaneous nephrostomy or ureteral stenting 2

Definitive Surgical Management

When conservative management fails or patient is not a candidate:

Primary option: Ureteroscopy (URS)

• URS during pregnancy demonstrates safety equivalent to non-pregnant patients regarding endoscopic complications 1
• Obstetric complication risk is 4.3% (including preterm labor), consistent with non-urologic surgery during pregnancy 1
• Coordination with obstetrics is essential - ACOG recommends notification and perioperative/intraoperative fetal monitoring 1
• While second trimester is preferred timing, medically necessary surgery should not be denied or delayed in third trimester 1

Alternative temporizing option: Ureteral stent or nephrostomy tube

• Can be offered as alternative to URS 1
• Important limitation: Requires frequent tube changes during pregnancy 1
• May become blocked, necessitating replacement or conversion to nephrostomy 3

Clinical Decision Algorithm

1. Confirm diagnosis: US → MRI if needed → low-dose CT only if absolutely necessary
2. Assess severity:
   • Sepsis/anuria → urgent decompression
   • Well-controlled symptoms → trial of passage
   • Failed conservative management or intractable pain → proceed to step 3
3. Definitive management:
   • Preferred: URS with obstetric coordination
   • Alternative: Temporary drainage (stent/nephrostomy) with frequent changes until postpartum definitive treatment

Key Pitfalls to Avoid

• Do not use NSAIDs in third trimester - switch to opioids for pain control
• Do not rely on tamsulosin - evidence does not support efficacy in pregnancy 1
• Do not delay necessary surgery - ACOG states medically necessary surgery should proceed regardless of trimester 1
• Do not forget frequent stent changes - pregnancy-related stent encrustation occurs more rapidly
• Do not skip obstetric involvement - coordinate all imaging and surgical decisions with obstetric team 1

The 2026 AUA guideline 1 provides the most recent and authoritative recommendations, emphasizing that URS is safe and effective during pregnancy when conservative management is unsuccessful, with appropriate obstetric coordination and informed consent regarding the 4.3% obstetric complication risk.